Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/9218205/marianne-thellersen-on-copenhagen <p><div><h2>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS</h2></div><div><p>Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.</p><p>Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.</p><p>To read more, please visit&nbsp;<a href="http://copenhagenspin-outs.dk/">http://copenhagenspin-outs.dk/</a></p></div></p><p><a href="http://biologictube.dk/photo/9218205/marianne-thellersen-on-copenhagen"><img src="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/9218205 Thu, 23 Jan 2014 11:08:04 GMT Marianne Thellersen on Copenhagen Spin-outs COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.To read more, please visithttp://copenhagenspin-outs.dk/ COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on... Welcome to the BioLogicTube 02:38 <p><div><h2>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS</h2></div><div><p>Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.</p><p>Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.</p><p>To read more, please visit&nbsp;<a href="http://copenhagenspin-outs.dk/">http://copenhagenspin-outs.dk/</a></p></div></p><p><a href="http://biologictube.dk/photo/9218205/marianne-thellersen-on-copenhagen"><img src="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Biologicmedia Denmarks technical University Gert Balling IPR Tech trans commercialization from bench to bedside improving innovation motivation spin out http://biologictube.dk/photo/9208451/prorector-thomas-bjornholm-and <p><div><div><h2>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS</h2></div></div><div><p>Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.</p><p>Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.</p><p>To read more, please visit&nbsp;<a href="http://copenhagenspin-outs.dk/">http://copenhagenspin-outs.dk/</a></p></div></p><p><a href="http://biologictube.dk/photo/9208451/prorector-thomas-bjornholm-and"><img src="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/9208451 Tue, 21 Jan 2014 10:48:53 GMT Prorector Thomas Bjørnholm and Copenhagen Spin-outs COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.To read more, please visithttp://copenhagenspin-outs.dk/ COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on... Welcome to the BioLogicTube 03:52 <p><div><div><h2>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS</h2></div></div><div><p>Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.</p><p>Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.</p><p>To read more, please visit&nbsp;<a href="http://copenhagenspin-outs.dk/">http://copenhagenspin-outs.dk/</a></p></div></p><p><a href="http://biologictube.dk/photo/9208451/prorector-thomas-bjornholm-and"><img src="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Gert Balling Venture commercialization entrepreneurship from bench to bedside invest ipr patents research start-up university http://biologictube.dk/photo/7529380/the-value-of-spin-outs-by <p>What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.<br></p><p><a href="http://biologictube.dk/photo/7529380/the-value-of-spin-outs-by"><img src="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7529380 Tue, 29 Jan 2013 20:18:54 GMT The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen... What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides. What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides. Welcome to the BioLogicTube 31:45 <p>What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.<br></p><p><a href="http://biologictube.dk/photo/7529380/the-value-of-spin-outs-by"><img src="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> IPR biotech biotek capital creation danish dansk job region research talents technology transfer http://biologictube.dk/photo/7530049/wim-bens-talks-about-his <p><p>Experience from the Netherlands in setting up University Spin-outs <b>Wim Bens</b>, Director, Bens &amp; Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy and implementation from lab invention to successful enterprise through different stages, with different funding structures, with different teams and in different organizational settings.</p></p><p><a href="http://biologictube.dk/photo/7530049/wim-bens-talks-about-his"><img src="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7530049 Mon, 31 Dec 2012 14:47:32 GMT Wim Bens talks about his experience from the Netherlands in setting up... Experience from the Netherlands in setting up University Spin-outs Wim Bens, Director, Bens Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy and implementation from lab invention to successful enterprise through different stages, with different funding structures, with different teams and in different organizational settings. Experience from the Netherlands in setting up University Spin-outs Wim Bens, Director, Bens Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy... Welcome to the BioLogicTube 01:09:00 <p><p>Experience from the Netherlands in setting up University Spin-outs <b>Wim Bens</b>, Director, Bens &amp; Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy and implementation from lab invention to successful enterprise through different stages, with different funding structures, with different teams and in different organizational settings.</p></p><p><a href="http://biologictube.dk/photo/7530049/wim-bens-talks-about-his"><img src="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> IPR building business copebhagen outs patents private public spin technology techtrans transfer http://biologictube.dk/photo/7530745/jeff-skinner-director-london <p><p><b>Jeff Skinner</b>&nbsp;is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.</p><p>He is past President of and remains closely involved with the leading UK &amp; European Tech Transfer Associations (PraxisUnico &amp; ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.</p><p>Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.</p></p><p><a href="http://biologictube.dk/photo/7530745/jeff-skinner-director-london"><img src="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7530745 Mon, 31 Dec 2012 14:43:27 GMT Jeff Skinner, Director, London Business School, talks on his experience from... Jeff Skinneris the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.He is past President of and remains closely involved with the leading UK European Tech Transfer Associations (PraxisUnico ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School. Jeff Skinneris the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is... Welcome to the BioLogicTube 01:06:00 <p><p><b>Jeff Skinner</b>&nbsp;is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.</p><p>He is past President of and remains closely involved with the leading UK &amp; European Tech Transfer Associations (PraxisUnico &amp; ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.</p><p>Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.</p></p><p><a href="http://biologictube.dk/photo/7530745/jeff-skinner-director-london"><img src="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Balling Copenhagen Gert IPR Spin biotech building chain innovation outs patents value http://biologictube.dk/photo/7529488/jens-kristian-damgaard <p>Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. <br><br><br></p><p><a href="http://biologictube.dk/photo/7529488/jens-kristian-damgaard"><img src="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7529488 Sun, 30 Dec 2012 20:13:22 GMT Jens Kristian Damgaard; Challenges in creating companies in the field between... Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. Welcome to the BioLogicTube 34:49 <p>Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. <br><br><br></p><p><a href="http://biologictube.dk/photo/7529488/jens-kristian-damgaard"><img src="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Balling Gert IPR MTA collaboration outs patents spin technology transfer http://biologictube.dk/photo/7525099/henric-rhedin-talks-on-the <p><p>Sweden’s so called innovation system; a spin out creation system. <br></p><p>Henric Rhedin. Director of Sales &amp; Marketing, Commercial Research &amp; Development. Chalmers Industriteknik, Gothenburg In Sweden there has been a focus on creating spin outs as commercialization strategy. What are the advan-tages/ disadvantages with a “spin out creation system” compared to more regular “innovation systems</p><p>Chalmers Industrial Technologies (CIT) is Sweden ́s oldest technology transfer organization and dates back to 1984. Henric works since nine years back for the largest unit at CIT, 35 people out of a total of 75 people employed by CIT. The unit, Commercial R&amp;D, provides expertise in all kinds of areas of technology including technology management and related services.</p> <p>Henric is board member for several start up companies as well as organizations. In addition to this Henric is active in innovation system networks on the national as well as on the international level including Association of Science and Technology Transfer Professional (ASTP), HEP TTN a CERN centered network for technology transfer activities for high energy physics, Swedish Network for Innovation and Tech Transfer Support (SNITTS) and Nordic Tech Transfer Network Health (NORTTH). Henric has also worked in the Swedish defense industry and has a PhD in Theoretical High Energy Physics.</p><br></p><p><a href="http://biologictube.dk/photo/7525099/henric-rhedin-talks-on-the"><img src="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7525099 Sat, 29 Dec 2012 16:06:01 GMT Henric Rhedin talks on the swedish innovator system Sweden’s so called innovation system; a spin out creation system. Henric Rhedin. Director of Sales Marketing, Commercial Research Development. Chalmers Industriteknik, Gothenburg In Sweden there has been a focus on creating spin outs as commercialization strategy. What are the advan-tages/ disadvantages with a “spin out creation system” compared to more regular “innovation systemsChalmers Industrial Technologies (CIT) is Sweden ́s oldest technology transfer organization and dates back to 1984. Henric works since nine years back for the largest unit at CIT, 35 people out of a total of 75 people employed by CIT. The unit, Commercial RD, provides expertise in all kinds of areas of technology including technology management and related services. Henric is board member for several start up companies as well as organizations. In addition to this Henric is active in innovation system networks on the national as well as on the international level including Association of Science and Technology Transfer Professional (ASTP), HEP TTN a CERN centered network for technology transfer activities for high energy physics, Swedish Network for Innovation and Tech Transfer Support (SNITTS) and Nordic Tech Transfer Network Health (NORTTH). Henric has also worked in the Swedish defense industry and has a PhD in Theoretical High Energy Physics. Sweden’s so called innovation system; a spin out creation system. Henric Rhedin. Director of Sales Marketing, Commercial Research Development. Chalmers Industriteknik, Gothenburg In Sweden there has been a focus on creating spin outs as... Welcome to the BioLogicTube 33:15 <p><p>Sweden’s so called innovation system; a spin out creation system. <br></p><p>Henric Rhedin. Director of Sales &amp; Marketing, Commercial Research &amp; Development. Chalmers Industriteknik, Gothenburg In Sweden there has been a focus on creating spin outs as commercialization strategy. What are the advan-tages/ disadvantages with a “spin out creation system” compared to more regular “innovation systems</p><p>Chalmers Industrial Technologies (CIT) is Sweden ́s oldest technology transfer organization and dates back to 1984. Henric works since nine years back for the largest unit at CIT, 35 people out of a total of 75 people employed by CIT. The unit, Commercial R&amp;D, provides expertise in all kinds of areas of technology including technology management and related services.</p> <p>Henric is board member for several start up companies as well as organizations. In addition to this Henric is active in innovation system networks on the national as well as on the international level including Association of Science and Technology Transfer Professional (ASTP), HEP TTN a CERN centered network for technology transfer activities for high energy physics, Swedish Network for Innovation and Tech Transfer Support (SNITTS) and Nordic Tech Transfer Network Health (NORTTH). Henric has also worked in the Swedish defense industry and has a PhD in Theoretical High Energy Physics.</p><br></p><p><a href="http://biologictube.dk/photo/7525099/henric-rhedin-talks-on-the"><img src="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Experience IPR biotech commercialization patents technology transfer